Atrium Therapeutics Reports First Quarter 2026 Financial Results
Go back to Atrium Therapeutics Reports First Quarter 2026 Financial Results| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 12.34 +0.23 (1.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.11 | 52 Week High | $22.80 | |||
| Open | $12.15 | 52 Week Low | $4.12 | |||
| Day High | $12.49 | P/E | N/A | |||
| Day Low | $12.15 | EPS | $0.00 | |||
| Volume | 103,287 | |||||
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 12.34 +0.23 (1.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.11 | 52 Week High | $22.80 | |||
| Open | $12.15 | 52 Week Low | $4.12 | |||
| Day High | $12.49 | P/E | N/A | |||
| Day Low | $12.15 | EPS | $0.00 | |||
| Volume | 103,287 | |||||
